These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection. Grof P; Alda M; Grof E; Fox D; Cameron P Br J Psychiatry Suppl; 1993 Sep; (21):16-9. PubMed ID: 8217062 [TBL] [Abstract][Full Text] [Related]
27. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment. George MS; Rosenstein D; Rubinow DR; Kling MA; Post RM Psychiatry Res; 1994 Feb; 51(2):139-46. PubMed ID: 8022948 [TBL] [Abstract][Full Text] [Related]
29. Thrombocytopenia associated with carbamazepine: case report and review. Baciewicz G; Yerevanian BI J Clin Psychiatry; 1984 Jul; 45(7):315-6. PubMed ID: 6735991 [TBL] [Abstract][Full Text] [Related]
30. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients]. Lemke MR; Stuhlmann W Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323 [TBL] [Abstract][Full Text] [Related]
31. [A clinical study on combined lithium and carbamazepine treatment of major affective disorders]. Chen CC; Ko WK Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Mar; 3(3):176-81. PubMed ID: 3482282 [No Abstract] [Full Text] [Related]
32. Saliva for monitoring of patients with primary affective disorders. Ben-Aryeh H; Laor R; Szargel R; Gutman D; Naon H; Pascal M; Hefetz A Isr J Med Sci; 1984 Mar; 20(3):197-201. PubMed ID: 6427134 [TBL] [Abstract][Full Text] [Related]